Clinical trials testing new diabetes treatments happen across the country every single day. These research studies involve real people—volunteers who work with doctors and researchers to test whether new medicines, devices, or approaches actually work. Understanding what these studies are helps you decide whether learning more about participation might make sense for you or a family member.
Learn About Paying Your FGUA Bill Online →
A diabetes treatment study might test a new insulin formulation that works differently than current options. Another might explore whether a particular medication reduces complications like kidney damage. Some studies look at behavioral approaches—like whether text message reminders help people stick to their medication schedules. Others test cutting-edge technology, such as improved continuous glucose monitors or automated insulin delivery systems.
The National Institutes of Health reports that over 3,000 diabetes-related clinical trials are actively recruiting participants in the United States at any given time. These range from small university-based studies with 20 participants to massive multi-center trials involving thousands of people across dozens of hospitals and clinics. Each one exists because a researcher believes they've found something worth testing that might help people manage diabetes better.
Why does this matter to you? The treatments doctors use today started as studies like these. The insulin pump technology millions rely on, continuous glucose monitoring systems, and many of the medications currently prescribed all went through clinical trial phases first. By learning about studies near you, you gain insight into what researchers are working on and what options may eventually become available to the broader diabetes community.
Practical takeaway: Diabetes treatment studies test new medicines, devices, and approaches. Knowing they exist and what they involve helps you understand the landscape of diabetes research happening in your region.
Finding diabetes treatment studies near where you live starts with knowing where to look. The most direct resource is ClinicalTrials.gov, a U.S. National Library of Medicine database that lists virtually every clinical trial happening in America. You can search by condition (diabetes), location (your city or state), and study phase. The site doesn't require any registration and provides straightforward information about what each study involves.
Free Guide to Pay by Plate Illinois Billing →
When you visit ClinicalTrials.gov, use the search filters to narrow results. Type "diabetes" in the condition field, then enter your city or choose your state. You'll see a list of active studies with titles, recruiting status, and brief descriptions. Each study has a detail page showing the research question, who's conducting it, where it's taking place, and contact information. Some entries include a link to the actual research facility's website for more details.
Beyond the national database, contact your local hospital's research department or endocrinology clinic directly. Many hospitals have research coordinators whose job is answering questions about studies they're running. Call the main number, ask for the research coordinator, and explain you're interested in learning about diabetes studies. They can tell you about trials you might not find online yet, since some studies recruit through word-of-mouth or provider referrals first.
University medical centers and large academic hospitals typically run more studies than smaller facilities. If you live near a major university, search that institution's name plus "clinical trials" to find their research portal. Many academic medical centers maintain their own trial-listing sites in addition to posting on ClinicalTrials.gov. Some also have social media pages or email newsletters announcing new studies.
Endocrinology practices and diabetes specialty clinics often know about studies their patients might fit. Your own doctor can be a valuable resource—they may know about trials recruiting people with your specific diabetes type or circumstances. Mention to your care team that you're interested in learning about research studies, and they can alert you if something relevant opens up.
Practical takeaway: Start with ClinicalTrials.gov, contact your local hospital's research department, and ask your doctor. These three approaches together will reveal most studies happening near you.
When you find a study listing, you'll see specific information presented in a standard format. Knowing how to read this information helps you quickly understand whether you want to learn more. Every study on ClinicalTrials.gov includes a title, study phase, recruitment status, and basic description—but there's much more detail available if you dig into the full entry.
Free Guide to Mold Removal Methods for Walls →
The study phase tells you how far along the research is. Phase 1 studies involve small groups (20-100 people) testing safety and dosage of something entirely new. Phase 2 studies (100-500 participants) continue testing safety while beginning to measure whether it actually works. Phase 3 studies (1,000-5,000 participants) compare the new approach against standard treatment to see if it's better. Phase 4 studies happen after something is already approved and being used, monitoring long-term results. Understanding the phase helps you grasp the maturity of the research.
The recruitment status section tells you whether a study is actively recruiting new people, not yet open, or closed. "Actively recruiting" means they're currently accepting participants. "Enrolling by invitation" means they're not accepting walk-ups but may accept people referred by their doctor. "Not yet recruiting" means they're preparing but haven't started accepting people yet. "Closed to recruitment" or "recruiting completed" means that phase has ended. This status changes frequently, so finding a study that's recruiting today is your indicator to move forward if interested.
The study description explains the research question in plain language. A good description tells you what condition is being studied, what treatment or approach is being tested, and why researchers think it might work. Look for sections labeled "Study Description" or "Detailed Description." These often explain the hypothesis—the educated guess researchers are testing—and what makes this particular approach different from existing options.
Inclusion and exclusion criteria tell you who can and cannot participate. These might specify age ranges, diabetes type (Type 1 versus Type 2), how long someone needs to have had diabetes, other health conditions that would disqualify someone, or medication requirements. This information matters because it tells you upfront whether participation would even be possible based on your or someone else's circumstances.
Contact information appears in every listing—usually a principal investigator's name, email, phone number, and the site location. This is your direct line to ask questions. The contact person can answer specific questions a database listing can't address, like whether your particular medical situation fits, what the time commitment looks like, or whether there's transportation support available.
Practical takeaway: Study phase shows research maturity, recruitment status shows whether they're accepting people now, and inclusion/exclusion criteria tell you upfront if participation is even possible for you. Contact information lets you ask questions the listing doesn't answer.
Diabetes research takes many different forms. Understanding the main categories helps you recognize what studies are actually testing when you're reviewing options. The approaches vary significantly in what's involved and what researchers hope to learn.
How to Delete Your Fitbit Account Guide →
Medication trials test new drugs or existing drugs in new ways. A researcher might be studying a new class of medication that works on diabetes differently than insulin or metformin. Another trial might test whether combining two existing drugs produces better results than either alone. Some medication studies involve injections; others involve pills. Many compare the new medication directly against a standard treatment to see if it performs better. The FDA reports that between 2015 and 2020, it approved 14 new diabetes medications—all of which came from studies like those you might find near you.
Device studies test new technology. This includes continuous glucose monitors with improved accuracy, insulin pumps with better automation features, or even artificial pancreas systems that automatically adjust insulin delivery. Device trials often require participants to wear or use new equipment and provide feedback about how well it works in real life. These studies are typically more intensive than medication trials because the technology often requires training and daily interaction.
Behavioral and lifestyle studies examine whether specific approaches—coaching programs, social support structures, exercise regimens, dietary interventions, or digital tools—help people manage diabetes more effectively. These studies might involve regular video calls with a health coach, attendance at group sessions, or using an app to track patterns. They tend to emphasize how people's daily habits and mindsets affect their diabetes management.
Combination or comprehensive studies test multiple components together. A researcher might test a new medication plus a behavioral coaching program, or a new device plus dietary guidance. These studies aim to understand how different elements work together, recognizing that diabetes management involves both medical treatment and personal actions.
Observational studies don't test a new treatment—instead, researchers follow people over time to understand
This guide is for general information only and is not medical, financial, legal, or other professional advice. For decisions specific to your situation, consult a qualified professional. See our Editorial Policy.